Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of FG-4592”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Early research (Phase 1)Study completedNCT02161796
What this trial is testing

Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects

Who this might be right for
PK for FG-4592Healthy Subjects
Astellas Pharma Europe B.V. 48
Large-scale testing (Phase 3)WithdrawnNCT04621331
What this trial is testing

Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

Who this might be right for
Anemia Associated With Chronic Kidney Disease
Kyntra Bio
Large-scale testing (Phase 3)Looking for participantsNCT05970172
What this trial is testing

Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseRenal Anemia
Astellas Pharma Global Development, Inc. 100
Early research (Phase 1)Study completedNCT02252731
What this trial is testing

Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects

Who this might be right for
Pharmacokinetics of FG-4592Healthy Subjects
Astellas Pharma Europe B.V. 22
Early research (Phase 1)Study completedNCT00978198
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male Volunteers

Who this might be right for
Healthy Volunteers
Astellas Pharma Inc 100
Early research (Phase 1)Study completedNCT02161224
What this trial is testing

Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function

Who this might be right for
PK of FG-4592Hepatic InsufficiencyHealthy Subjects
Astellas Pharma Europe B.V. 16
Early research (Phase 1)Study completedNCT02965040
What this trial is testing

Roxadustat in Subjects With Different Degrees of Renal Function

Who this might be right for
Normal Renal FunctionImpaired Renal Function
Astellas Pharma Europe B.V. 34
Early research (Phase 1)Study completedNCT01083888
What this trial is testing

ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis

Who this might be right for
AnemiaHemodialysisRenal Impairment
Astellas Pharma Inc 12
Early research (Phase 1)Study completedNCT03960489
What this trial is testing

Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult Subjects

Who this might be right for
Healthy Adult Subjects
Astellas Pharma Global Development, Inc. 24